19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.
@article{Numazawa199919oxygenatedDO, title={19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.}, author={M. Numazawa and K. Yamada and K. Kidokoro}, journal={Biological & pharmaceutical bulletin}, year={1999}, volume={22 10}, pages={ 1134-6 } }
To gain insight into the binding manner of androst-4-ene-6,17-dione (4) and its 5-en-4-one analog 9, good competitive inhibitors of aromatase, in the active site of the enzyme, their 19-oxygenated derivatives were evaluated as inhibitors of human placental aromatase. The 19-hydroxy steroids 6, 7, and 10 and the 19-oxo analogs 8 and 12 were much poorer competitive inhibitors than their corresponding parent 19-methyl steroids. Conversion of the 17-keto inhibitors 4, 6, and 10 to the 17beta-ols 5… CONTINUE READING
Topics from this paper
3 Citations
Aromatase inhibitors: past, present and future
- Biology, Medicine
- Molecular and Cellular Endocrinology
- 2001
- 101
Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
- Medicine, Chemistry
- European journal of medicinal chemistry
- 2020
References
Aromatase and its inhibitors in breast cancer treatment — overview and perspective
- Biology, Medicine
- Breast Cancer Research and Treatment
- 2004
- 32